0001179110-20-007056.txt : 20200605
0001179110-20-007056.hdr.sgml : 20200605
20200605184036
ACCESSION NUMBER: 0001179110-20-007056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200605
FILED AS OF DATE: 20200605
DATE AS OF CHANGE: 20200605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coleman Mark
CENTRAL INDEX KEY: 0001658379
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37635
FILM NUMBER: 20947678
MAIL ADDRESS:
STREET 1: 25 BROADWAY
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10004
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axsome Therapeutics, Inc.
CENTRAL INDEX KEY: 0001579428
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454241907
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BROADWAY, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10038
BUSINESS PHONE: (212) 332-3241
MAIL ADDRESS:
STREET 1: 200 BROADWAY, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10038
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-05
0
0001579428
Axsome Therapeutics, Inc.
AXSM
0001658379
Coleman Mark
C/O AXSOME THERAPEUTICS, INC.
200 BROADWAY, 3RD FLOOR
NEW YORK
NY
10038
1
0
0
0
Stock Option (Right to Buy)
77.38
2020-06-05
4
A
0
13000
0
A
2021-06-05
2030-06-05
Common Stock
13000
13000
D
The option vests in full on the one-year anniversary of the date of grant, June 5, 2021.
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
2020-06-05